… imaging and/or the presence of restrictive disorders in pulmonary function tests (PFTs). ILD
is one of the leading causes of death in systemic sclerosis patients. Major risk factors of ILD …

… fibrosing ILD for repeat pulmonary function tests is between 3 … pulmonary function tests and
HRCT in stable ILD is required. … with CT imaging play a role in management decisions and …

… to the ascertainment technique: pulmonary function testing, chest computed tomography, or
… pattern on imaging and more severe impairment of lung function, suggesting a possible role …

… Interstitial lung disease are a group of heterogenous … Pulmonary function tests (PFT) have a
role in the management of … often have difficulty in performing simple spirometry and are often …

… Objective assessment of disease severity using pulmonary function tests is usual at
diagnosis, with serial measurements at follow-up intervals to track progression and the impact of …

… in lung diseases. Exertional dyspnoea is commonly evaluated using respiratory investigations
including pulmonary function tests … a similar role as it does in other chronic lung diseases, …

… and smoking status, they enrolled 40 ILD patients and 16 healthy volunteers who underwent
LUS examination and pulmonary functional test. Initially LUS were performed using a 2–5 …

… pulmonary function testing and the Six-Minute Walk Test (6MWT), as well as neuropsychological
assessment. Inclusion criteria for ILD patients were as follows: (a) having … play a role in …

… , and there are several commercially available tests for measuring telomere … , disease
severity and response to treatment are often monitored in the clinic using pulmonary function tests …

… Given the role of exposures in ILD and the significance of … testing, chest computed
tomography (CT) imaging, and lung biopsy if appropriate. Pulmonary function testing (PFTs) are …